These established short-term safety and pharmacology context but were not designed to demonstrate weight loss efficacy
doi: 189
Furthermore, other recently implicated factorssuch as disruptions in the gut microbiome, excessive iodine intake, stress, and epigenetic changesfurther underscore the multifactorial nature of this disorder
Understanding the actual mechanisms behind GLP-1 therapy helps patients and clinicians set realistic expectations for treatment outcomes and recognize that successful weight management with these agents requires active participation in dietary modifications alongside medication use
If you have elevated B12 and symptoms like fatigue, weight loss, or abdominal pain, the symptoms are likely from the underlying cause of the elevation , not from the B12 itself
Compared with similar people who didnt take GLP-1 medications, those who did had about a 50% higher risk of being diagnosed with the condition